PLEASANTON, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ProSomnus Sleep Technologies (the "Company"), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced record revenues for the quarter ended June 30, 2024 as it formally emerges from reorganization on August 5, 2024. Revenues for the second quarter totaled a record $9.1 million reflecting increasing orders for the Company's precision intraoral medical devices. These quarterly results reflect a 22% increase over the first quarter of 2024, a 31% increase over the same quarter in 2023 and the 9th record revenue quarter over the past 10 sequential quarters. Year-to-date 2024 revenues totaled $16.6M, a 30% increase over the first half of 2023. Operating expenses year-to-date decreased 25% to $12.5 million from $16.7 million. Effective August 5, 2024, the transactions contemplated by the ...